CAPRICOR THERAPEUTICS, INC. Stock Agreements
15 Contracts & Agreements
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 11, 2024)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 17, 2023)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 11, 2022)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 15, 2021)
- Description of the Companys Common Stock, par value $0.001 per share (Filed With SEC on March 27, 2020)
- Common Stock Sales Agreement, dated July 22, 2019, between Capricor Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 22, 2019)
- Common Stock Sales Agreement, dated October 19, 2017, between Capricor Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 19, 2017)
- CAPRICORTHERAPEUTICS, INC. $5,000,000 cOMMON STOCK SALES AGREEMENT (Filed With SEC on March 31, 2017)
- NILETHERAPEUTICS, INC. WarrantTo Purchase Common Stock (Filed With SEC on April 2, 2012)
- NILE THERAPEUTICS, INC. 3,350,000 shares of Common Stock and Warrants to purchase up to 2,512,500shares of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on April 2, 2012)
- NILETHERAPEUTICS, INC. REPRESENTATIVESWARRANT 390,000shares of Common Stock April21, 2010 (Filed With SEC on April 22, 2010)
- Nile Therapeutics, Inc. Stock Option Agreement (Non-Statutory) (Filed With SEC on September 21, 2007)
- NILE THERAPEUTICS, INC. Amended and Restated 2005 Stock Option Plan (Filed With SEC on September 21, 2007)
- Incorporated under the laws of the State of Delaware -[CERT #]- *[NUMBER OF SHARES]* NILE THERAPEUTICS, INC. COMMON STOCK 100,000,000 Authorized (Filed With SEC on September 21, 2007)
- STOCK PURCHASE AGREEMENT (Filed With SEC on August 14, 2006)
